MyAmyloidosisTeam

Wild-type ATTR amyloidosis generally has a better prognosis compared to hereditary ATTR amyloidosis (hATTR). Here are the key points:

- Wild-type ATTR amyloidosis
- Typically diagnosed in people aged 65 or older.
- Develops slowly over time as amyloid deposits form.
- Prognosis is generally better than for AL Show Full Answer

Wild-type ATTR amyloidosis generally has a better prognosis compared to hereditary ATTR amyloidosis (hATTR). Here are the key points:

- Wild-type ATTR amyloidosis:
- Typically diagnosed in people aged 65 or older.
- Develops slowly over time as amyloid deposits form.
- Prognosis is generally better than for AL amyloidosis or hATTR amyloidosis.

- Hereditary ATTR amyloidosis (hATTR):
- Life expectancy is about 4.7 years after diagnosis for half of the people.
- New treatments are extending life expectancy by stabilizing TTR proteins or stopping their production.

In summary, wild-type ATTR amyloidosis tends to have a better life expectancy compared to hereditary ATTR amyloidosis.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

What’s the Life Expectancy With hATTR Amyloidosis? | MyAmyloidosisTeam

Life Expectancy With Amyloidosis | MyAmyloidosisTeam